Vident Investment Advisory’s Genetron Holdings Limited ADS GTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-7,316
Closed -$37K 1369
2022
Q2
$37K Hold
7,316
﹤0.01% 1249
2022
Q1
$48K Buy
7,316
+2,785
+61% +$30.5K ﹤0.01% 1247
2021
Q4
$83K Sell
4,531
-1,193
-21% -$39.5K ﹤0.01% 1186
2021
Q3
$238K Buy
+5,724
New +$264K 0.01% 1050
2021
Q2
Sell
-3,211
Closed -$207K 1121
2021
Q1
$207K Sell
3,211
-2,790
-46% -$192K 0.01% 961
2020
Q4
$252K Hold
6,001
0.01% 845
2020
Q3
$215K Buy
+6,001
New +$231K 0.01% 827

Other funds holding GTH

Vident Investment Advisory's GTH Position: Q3 2022 in Review

Vident Investment Advisory sold out of Genetron Holdings Limited ADS (GTH) in Q3 2022, closing a stake of 7,316 shares — an estimated $37K sold.

Vident Investment Advisory first reported a position in GTH in Q3 2020 and held it in 7 quarters. The position peaked at $252K in Q4 2020. 25 funds tracked by Wall St. Rank hold GTH as of Q3 2022.

  • Vident Investment Advisory reported no remaining Genetron Holdings Limited ADS position as of Q3 2022 after selling out during the quarter.
  • Vident Investment Advisory sold 7,316 Genetron Holdings Limited ADS shares in Q3 2022, an estimated $37K.
  • Vident Investment Advisory first reported a position in Genetron Holdings Limited ADS in Q3 2020 and held it in 7 quarters.
  • Vident Investment Advisory's Genetron Holdings Limited ADS position peaked at $252K in Q4 2020.
  • 25 funds tracked by Wall St. Rank held Genetron Holdings Limited ADS as of Q3 2022.

Based on Vident Investment Advisory's 13F filing for Q3 2022, filed 14 Nov 2022.